Neesha Dhani

6PUBLICATIONS
78CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jan 21, 2025
Randomized Phase II Study of Bevacizumab with Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant/Refractory High-Grade Ovarian Cancer (NCI Trial).

Husam A Alqaisi, David E Cohn, Jing-Yi Chern

|Nov 30, 2023
FBXW7-loss Sensitizes Cells to ATR Inhibition Through Induced Mitotic Catastrophe.

Siobhan O'Brien, Tajinder Ubhi, Lucie Wolf

|Sep 12, 2023
Rerouting the GPS Directing Immunotherapy in Endometrial Cancer.

Rhea Jangra, Neesha C Dhani

|Jun 21, 2023
Symptom screening with Targeted Early Palliative care (STEP) versus usual care for patients with advanced cancer: a mixed methods study.

Camilla Zimmermann, Ashley Pope, Breffni Hannon

|Jun 16, 2023
Identifying Mechanisms of Resistance by Circulating Tumor DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at Time of PARP Inhibitor Progression.

Stephanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield

|Aug 29, 2022
A Phase II Randomized Trial of Chemoradiation with or without Metformin in Locally Advanced Cervical Cancer.

Kathy Han, Anthony Fyles, Tina Shek

Pageof 1